← Every company

Alnylam Pharmaceuticals Inc Insider Trading

Every director, officer and 10% holder of Alnylam Pharmaceuticals Inc has to report each trade in its stock within two business days of making it. This is those filings.

ALNY on carbonthat →
Insiders filing
2
2 reported lines
Open-market buys
0
Open-market sales
1
$398.9K
Net
$398.9K
sold more

Purchases and sales

Open-market trades only — the lines where someone chose to buy or sell at the going price.

InsiderActionValue
Bryan SupranEVP, CLO and Secretary2026-10-021.8K shat $226.88
Sale
$398.9K

Source: SEC Form 4 filings, via EDGAR. A derivative line reports the shares underlying an option rather than stock outstanding, so it is marked and is not comparable with the rest. Value is shares times the reported price, and is blank where the filing priced the transaction at zero — a grant costs its recipient nothing. Insiders sell for reasons that have nothing to do with the company, which is why a sale is not read as a signal on its own.

More on ALNY

Follow Alnylam Pharmaceuticals Inc (ALNY) by email

New trades in Alnylam Pharmaceuticals Inc (ALNY) by members of Congress, insiders and funds, with the rest of the week's filings. One email a week, free.

Unsubscribe with one click from any email.

Related datasets